OR WAIT null SECS
June 12, 2023
World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.
June 08, 2023
The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.
The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.
Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.
May 30, 2023
Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.
The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.
May 24, 2023
Ironwood Pharmaceuticals’ acquisition of VectivBio grants it the rights to apraglutide, a glucagon-like peptide being evaluated for gastrointestinal diseases.
May 17, 2023
Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.
May 16, 2023
In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.
The NSF-sponsored program aims to help partners collaborate to create opportunities for significant economic, societal, and technological opportunities for growth in their regions.